Mesa Laboratories, Inc.

NasdaqGS:MLAB Stock Report

Market Cap: US$564.1m

Mesa Laboratories (MLAB) Stock Overview

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. More details

MLAB fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Rewards

Trading at 24.3% below our estimate of its fair value

Earnings are forecast to grow 89.49% per year

Risk Analysis

No risks detected for MLAB from our risk checks.

MLAB Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Mesa Laboratories, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Mesa Laboratories
Historical stock prices
Current Share PriceUS$103.40
52 Week HighUS$155.12
52 Week LowUS$87.80
Beta0.89
1 Month Change3.28%
3 Month Change-4.26%
1 Year Change14.36%
3 Year Change-49.25%
5 Year Change-52.60%
Change since IPO3,276.33%

Recent News & Updates

Mesa Laboratories: Strong Order Growth And Positive Valuation Outlook

Jul 04

Recent updates

Mesa Laboratories: Strong Order Growth And Positive Valuation Outlook

Jul 04

We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt

Jun 18
We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt

Investors Interested In Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Revenues

Apr 01
Investors Interested In Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Revenues

At US$135, Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Worth Looking At Closely?

Feb 28
At US$135, Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Worth Looking At Closely?

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 22% Below Their Intrinsic Value Estimate

Jan 07
Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 22% Below Their Intrinsic Value Estimate

Mesa Laboratories: GKE Acquisition New Crown Jewel, Still Doesn't Move The Needle

Dec 19

Investors Give Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares A 25% Hiding

Nov 20
Investors Give Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares A 25% Hiding

We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt

Oct 17
We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt

A Piece Of The Puzzle Missing From Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 27% Share Price Climb

Jul 29
A Piece Of The Puzzle Missing From Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 27% Share Price Climb

Is Now An Opportune Moment To Examine Mesa Laboratories, Inc. (NASDAQ:MLAB)?

May 03
Is Now An Opportune Moment To Examine Mesa Laboratories, Inc. (NASDAQ:MLAB)?

Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?

Mar 15
Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?

Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 08
Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 43% Discount?

Dec 05
Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 43% Discount?

Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?

Sep 28
Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?

Estimating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Aug 09
Estimating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

We Think Mesa Laboratories (NASDAQ:MLAB) Is Taking Some Risk With Its Debt

Jun 28
We Think Mesa Laboratories (NASDAQ:MLAB) Is Taking Some Risk With Its Debt

Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking

May 31
Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking

A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Apr 12
A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?

Mar 13
Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?

Estimating The Fair Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Dec 20
Estimating The Fair Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Shareholder Returns

MLABUS Life SciencesUS Market
7D7.3%2.2%2.1%
1Y14.4%-15.6%14.3%

Return vs Industry: MLAB exceeded the US Life Sciences industry which returned -15.9% over the past year.

Return vs Market: MLAB exceeded the US Market which returned 13.2% over the past year.

Price Volatility

Is MLAB's price volatile compared to industry and market?
MLAB volatility
MLAB Average Weekly Movement6.9%
Life Sciences Industry Average Movement10.2%
Market Average Movement7.4%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market3.9%

Stable Share Price: MLAB has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: MLAB's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1982730Gary Owenswww.mesalabs.com

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries.

Mesa Laboratories, Inc. Fundamentals Summary

How do Mesa Laboratories's earnings and revenue compare to its market cap?
MLAB fundamental statistics
Market capUS$564.09m
Earnings (TTM)-US$1.97m
Revenue (TTM)US$240.98m
2.3x
P/S Ratio
-285.8x
P/E Ratio

Is MLAB overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MLAB income statement (TTM)
RevenueUS$240.98m
Cost of RevenueUS$88.88m
Gross ProfitUS$152.10m
Other ExpensesUS$154.08m
Earnings-US$1.97m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Aug 05, 2025

Earnings per share (EPS)-0.36
Gross Margin63.12%
Net Profit Margin-0.82%
Debt/Equity Ratio111.3%

How did MLAB perform over the long term?

See historical performance and comparison

Dividends

0.6%
Current Dividend Yield
-176%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/03 20:45
End of Day Share Price 2025/07/03 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mesa Laboratories, Inc. is covered by 8 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vijay KumarEvercore ISI
Paul KnightJanney Montgomery Scott LLC
Tycho PetersonJefferies LLC